摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,2,2,3,3,4,4,5,5,6,6-十一氟-N,N-二(1,1,2,2,2-五氟乙基)环己烷-1-胺 | 308-95-2

中文名称
1,2,2,3,3,4,4,5,5,6,6-十一氟-N,N-二(1,1,2,2,2-五氟乙基)环己烷-1-胺
中文别名
氨甲酸,[4-[(3aS,4S,6R,6aR)-6-[[[(1,1-二甲基乙基)二甲基甲硅烷基]氧代]甲基]四氢-2,2-二甲基-4H-1,3-二噁唑并[4,5-c]吡咯-4-基]-1-萘基]-,1,1-二甲基乙基酯(9CI)
英文名称
perfluoro(diethylcyclohexylamine)
英文别名
bis-pentafluoroethyl-undecafluorocyclohexyl-amine;Bis-pentafluoraethyl-undecafluorcyclohexyl-amin;perfluoro-N,N-diethylcyclohexylamine;Cyclohexanamine, 1,2,2,3,3,4,4,5,5,6,6-undecafluoro-N,N-bis(pentafluoroethyl)-;1,2,2,3,3,4,4,5,5,6,6-undecafluoro-N,N-bis(1,1,2,2,2-pentafluoroethyl)cyclohexan-1-amine
1,2,2,3,3,4,4,5,5,6,6-十一氟-N,N-二(1,1,2,2,2-五氟乙基)环己烷-1-胺化学式
CAS
308-95-2
化学式
C10F21N
mdl
——
分子量
533.083
InChiKey
YDSHWJILVOQURX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.5
  • 重原子数:
    32
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    3.2
  • 氢给体数:
    0
  • 氢受体数:
    22

SDS

SDS:2916d216cd746df859acc0005c018d29
查看

反应信息

点击查看最新优质反应信息

文献信息

  • Electrochemical fluorinatior of some cyclic tertiary amines
    作者:L. Conte、C. Fraccaro、M. Napoli、M. Mistrorigo
    DOI:10.1016/s0022-1139(00)85068-x
    日期:1986.12
    Electrochemical fluorination of N,N-diethylcyclohexylamine and N-ethyldicyclohexylamine gave the corresponding F-amines together with several other compounds arising from incomplete fluorination and fragmentation reactions. In the case of N,N-diethylcyclohexylamine yields of 51–52% were obtained and most of the reaction products were isolated and identified. With N-ethyldicyclohexylamine a lower yield
    N,N-二乙基环己胺和N-乙基二环己胺的电化学氟化反应产生了相应的F-胺,以及由于氟化和裂解反应不完全而产生的其他几种化合物。对于N,N-二乙基环己胺,产率为51–52%,大多数反应产物均已分离和鉴定。用N-乙基二环己基胺观察到较低的收率(16%)。所得的反应混合物太复杂而无法鉴定其成分。对反应机理进行了评论,并报告了已鉴定化合物的NMR和IR数据。
  • Perfusate for preserving organ to be transplanted and preserving method
    申请人:The Green Cross Corporation
    公开号:EP0033402A1
    公开(公告)日:1981-08-12
    An organ to be transplanted, such as a kidney, can effectively be preserved for an increased period of time by perfusion using a perfusate which is made of a Ringer's solution modified by increasing its potassium ion content to 8-20 meq/liter with a stably emulsified perfluorocarbon compound and dissolved albumin. A preferred concentration of the perfluorocarbon compound, for example perfluorodecalin, is 7.5 to 12.5%(W/V) and that of albumin is 1-8%(W/V) based on the perfusate.
    灌注液是由林格氏溶液改良而成,改良后的林格氏溶液将钾离子含量提高到 8-20 meq/升,并加入了稳定乳化的全氟碳化合物和溶解的白蛋白。全氟碳化合物(例如全氟萘烷)的优选浓度为 7.5-12.5%(W/V),白蛋白的优选浓度为灌流液的 1-8%(W/V)。
  • Concentrated stable fluorchemical aqueous emulsions
    申请人:AIR PRODUCTS AND CHEMICALS, INC.
    公开号:EP0282949A2
    公开(公告)日:1988-09-21
    A stable concentrated aqueous emulsion of perfluorochemical, a phos­pholipid and a triglyceride of fatty acids has been demonstrated which has enhanced stability, diminished particle size and heightened tolerance by biological systems. The emulsion has utility as an oxygen transport medium, such as artificial blood. The emulsion can optionally include addition emulsifiers of SURFYNOL®SE surfactant and PLURONIC® P-105 surfactant. The emulsion is produced using an improved emul­sification technique.
    一种由全氟化学品、磷脂和脂肪酸甘油三酯组成的稳定浓缩水乳液已经得到证实,它具有更高的稳定性、更小的粒径和更强的生物系统耐受性。这种乳液可用作氧气运输介质,如人造血液。乳液中还可添加 SURFYNOL®SE 表面活性剂和 PLURONIC® P-105 表面活性剂等乳化剂。该乳液采用改进的乳化技术制成。
  • Stable fluorocarbon aqueous emulsions
    申请人:AIR PRODUCTS AND CHEMICALS, INC.
    公开号:EP0282948A2
    公开(公告)日:1988-09-21
    A stable aqueous emulsion of perfluorochemical, a phospholipid and a triglyceride of fatty acids has been demonstrated which has enhanced stability, diminished particle size and heightened tolerance by bio­logical systems. The emulsion has utility as an oxygen transport medium, such as artificial blood.
    一种由全氟化学品、磷脂和脂肪酸甘油三酯组成的稳定水乳液已经得到证实,它具有更高的稳定性、更小的粒径和更强的生物系统耐受性。这种乳液可用作氧气运输介质,如人造血液。
  • Single-phase composition containing a perfluorinated oil and one or more surfactant(s), useful as an excipient for cosmetic and dermatologic formulations, as well as for biomedical applications
    申请人:ENIRICERCHE S.p.A.
    公开号:EP0296661A2
    公开(公告)日:1988-12-28
    A single-phase, either isotropic or anisotropic formulation is disclosed,which contains perfluorinated oil and one or more surfactant(s), is useful as an excipient for cosmetic and dermatologic formulations and is characterized in that at least one surfactant is selected from those having the following general formula: wherein: RF is an F-(CF₂-CF₂) i group; X is a group selected from: -(CH₂-O)K-; and -(CH₂-S)K-; wherein RI is a (C₁-C₄)-alkyl; Y is a group selected from: NH₂(RII)₂ and N(RII)₄; wherein RII is a hydrogen atom, or a group selected from -CH₂-CH₂-OH and (C₁-C₄)-alkyl; i is an integer comprised within the range of from 3 to 8; j is zero or 1; K is 2.l; l is an integer comprised within the range of from 1 to 10; m is 1 or 2. Such composition is spontaneously formed when the components are simply placed into contact with one another. In particular, in case of the isotropic form, the composition is a fluid, clear and stable composition, with particle size smaller than 400 Å , containing: (a) from 1 to 50% by weight of the perfluorinated oil; (b) from 1 to 50% by weight of water; (c) from 8 to 60% by weight of at least one surfactant selected from the above defined surfactants; (d) from 6 to 38% by weight of a co-surfactant, selected from (C₃-C₇)-aliphatic alcohols. In case of the anisotropic form, the composition has a high viscosity, and contains: (a) from 1 to 50% by weight of the perfluorinated oil; (b) from 1 to 80% by weight of water; (c) from 1 to 40% by weight of at least one surfactant selected from the above defined surfactants; (d) from 0 to 19% by weight of a co-surfactant, selected from (C₃-C₇)-aliphatic alcohols. Furthermore, in case of the isotropic composition this latter finds also use in the biomedical sector.
    本发明公开了一种各向同性或各向异性的单相制剂,它含有全氟油和一种或多种表面活性剂,可用作化妆品和皮肤科制剂的赋形剂,其特征在于至少一种表面活性剂选自具有以下通式的表面活性剂: 其中 RF 是 F-(CF₂-CF₂) i 基团; X 是选自以下的基团 -(CH₂-O)K-;和-(CH₂-S)K-; 其中 RI 是 (C₁-C₄)- 烷基; Y 是选自以下各项的基团 NH₂(RII)₂ 和 N(RII)₄; 其中 RII 是氢原子,或选自-CH₂-CH₂-OH 和 (C₁-C₄)- 烷基的基团; i 是 3 至 8 之间的整数; j 为 0 或 1; K 为 2.l; l 是 1-10 之间的整数; m 是 1 或 2。 当各组分简单地相互接触时,就会自发地形成这种组合物。 特别是在各向同性的情况下,这种组合物是一种流动、透明和稳定的组合物,其粒径小于 400 Å,含有以下成分: 1: (a) 1%至 50%(按重量计)的全氟油; (b) 1 至 50%(按重量计)的水; (c) 至少一种选自上述表面活性剂的表面活性剂,重量百分比为 8-60%; (d) 6-38%(重量)的助表面活性剂,选自(C₃-C₇)-脂肪醇。 在各向异性的情况下,组合物具有较高的粘度,并包含以下成分: (a) 1%至 50%(按重量计)的全氟油; (b) 1%至 80%(按重量计)的水 (c) 至少一种选自上述表面活性剂的表面活性剂(按重量计)(1-40%); (d) 0-19%(重量)的助表面活性剂,选自(C₃-C₇)-脂肪醇。 此外,对于各向同性组合物,后者也可用于生物医学领域。
查看更多

同类化合物

(N-(2-甲基丙-2-烯-1-基)乙烷-1,2-二胺) (4-(苄氧基)-2-(哌啶-1-基)吡啶咪丁-5-基)硼酸 (11-巯基十一烷基)-,,-三甲基溴化铵 鼠立死 鹿花菌素 鲸蜡醇硫酸酯DEA盐 鲸蜡硬脂基二甲基氯化铵 鲸蜡基胺氢氟酸盐 鲸蜡基二甲胺盐酸盐 高苯丙氨醇 高箱鲀毒素 高氯酸5-(二甲氨基)-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-2-甲基吡啶正离子 高氯酸2-氯-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-6-甲基吡啶正离子 高氯酸2-(丙烯酰基氧基)-N,N,N-三甲基乙铵 马诺地尔 马来酸氢十八烷酯 马来酸噻吗洛尔EP杂质C 马来酸噻吗洛尔 马来酸倍他司汀 顺式环己烷-1,3-二胺盐酸盐 顺式氯化锆二乙腈 顺式吡咯烷-3,4-二醇盐酸盐 顺式双(3-甲氧基丙腈)二氯铂(II) 顺式3,4-二氟吡咯烷盐酸盐 顺式1-甲基环丙烷1,2-二腈 顺式-二氯-反式-二乙酸-氨-环己胺合铂 顺式-二抗坏血酸(外消旋-1,2-二氨基环己烷)铂(II)水合物 顺式-N,2-二甲基环己胺 顺式-4-甲氧基-环己胺盐酸盐 顺式-4-环己烯-1.2-二胺 顺式-4-氨基-2,2,2-三氟乙酸环己酯 顺式-2-甲基环己胺 顺式-2-(苯基氨基)环己醇 顺式-2-(氨基甲基)-1-苯基环丙烷羧酸盐酸盐 顺式-1,3-二氨基环戊烷 顺式-1,2-环戊烷二胺 顺式-1,2-环丁腈 顺式-1,2-双氨甲基环己烷 顺式--N,N'-二甲基-1,2-环己二胺 顺式-(R,S)-1,2-二氨基环己烷铂硫酸盐 顺式-(2-氨基-环戊基)-甲醇 顺-2-戊烯腈 顺-1,3-环己烷二胺 顺-1,3-双(氨甲基)环己烷 顺,顺-丙二腈 非那唑啉 靛酚钠盐 靛酚 霜霉威盐酸盐 霜脲氰